financially supported by the National Natural Science Foundation of China(Nos.81473256 and 81273561);the CAMS Innovation Fund for Medical Sciences(No.2016-I2M-1014,China);the Science and Technology Program of Beijing(No.Z151100000115008,China);the Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study(No.BZ0150,China);the Drug Innovation Major Project(Nos.2015ZX09102-023 and 2018ZX09711001-003-002,China);the Disciplines Construction Project(No.201920200802,China)
The limited treatment options for the increasing occurrence of Lassa hemorrhagic fever in West Africa poses an urgent need for the discovery and development of novel therapeutics.Dietary supplements,especially natural...
supported by grants from the National Natural Science Foundation of China (81202568, 81473256, and 81273561);the National Science and Technology Major Project (2015ZX09102-023-004);the CAMS Innovation Fund for Medical Sciences (2016-I2M-1–014);the Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study (BZ0150)
Filoviruses cause severe and fatal viral hemorrhagic fever in humans. Filovirus research has been extensive since the 2014 Ebola outbreak. Due to their high pathogenicity and mortality, live filoviruses require Biosaf...